Biological Information
Background Information:
Protein kinase Cb2 (PKCb2) is one of the major protein kinase C isoforms of a family of serine/threonine protein kinases. Breakdown of phosphatidylinositol leads to formation of diacylglycerol and inositol triphophate, the former acting synergistically with Ca2+ to activate protein kinase C (PKC), resulting in translocation of the enzyme from cytosol to the membrane. Phosphorylation of proteins by PKC has been implicated as a pivotal regulatory element in signal transduction, cellular regulation, and with a high affinity to phorbol ester tumor promoters.
Family:
Kinase
Sub Family:
PKC
Class:
Protein Ser/Thr
Protein Name:
PKCbeta
Uniprot Number:
P05771
Gene Name:
PRKCB
Gene ID:
5579
Accession Number:
NM_212535
Organism:
Human
Construct Details:
Full Length, Recombinant
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Antagonist
Detection Method:
Radiometry
Measured Response:
Scintillation
Testing Information
Procedure Summary:
Human recombinant protein kinase PKCβ2 expressed in insect Sf21 cells is used. Test compound and/or vehicle is preincubated with 0.726 µg/ml enzyme in modified HEPES buffer pH 7.4 for 15 minutes at 37°C. The reaction is initiated by addition of 250 µg/ml histone type III-S, 10 µM ATP and 0.25 µCi [γ³²P]ATP for another 30-minute incubation period and terminated by further addition of 3% H₃PO₄. An aliquot is removed and counted to determine the amount of [³²P]Histone type III-S formed. Compounds are screened at 10 µM.
Substrate:
250 µg/ml Histone
ATP Concentration:
10 uM
Incubation:
30 min at 37°C
Control Inhibitor:
Staurosporine
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
10
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS